Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP8KY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,543
Award facts
- Contract value 100% obligated
- $41,543.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $41,543.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Dupixent 300 mg/2 ml pen injectors. This non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems including the Department of Defense and Veterans Affairs.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which functions as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Dupixent, a biologic medication used for treating atopic dermatitis and other inflammatory conditions, represents one of the specialized pharmaceutical products delivered through this strategic contract arrangement supporting military medical treatment facilities.
Quick answers
Who was awarded contract SPE2DR26FP8KY?
SPE2DR26FP8KY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FP8KY worth?
The government has obligated $41,543 on SPE2DR26FP8KY.
Is contract SPE2DR26FP8KY an order under another contract?
Yes. SPE2DR26FP8KY is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8KY competed?
The extent of competition for SPE2DR26FP8KY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award